Advanced search
Publication Cover
Leukemia & Lymphoma Volume 50, 2009 - Issue 6
Submit an article Journal homepage
277
Views
21
CrossRef citations to date
0
Altmetric
Original Article: Research

CD52 expression in peripheral T-cell lymphomas determined by combined immunophenotyping using tumor cell specific T-cell receptor antibodies

Eva Geissinger Institute of Pathology, University of Wuerzburg, GermanyCorrespondence[email protected]
,
Irina Bonzheim Institute of Pathology, University of Tuebingen, Germany
,
Sabine Roth Institute of Pathology, University of Wuerzburg, Germany
,
Andreas Rosenwald Institute of Pathology, University of Wuerzburg, Germany
,
Hans Konrad Müller-Hermelink Institute of Pathology, University of Wuerzburg, Germany
&
Thomas Rüdiger Institute of Pathology, Staedtisches Klinikum Karlsruhe, Germany
Pages 1010-1016 | Received 01 Feb 2009, Accepted 24 Mar 2009, Published online: 21 Jul 2009

Citations (21)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Elizabeth H. Phillips, Stephen Devereux, John Radford, Naheed Mir, Toyin Adedayo, Laura Clifton-Hadley & Rod Johnson. (2019) Toxicity and efficacy of alemtuzumab combined with CHOP for aggressive T-cell lymphoma: a phase 1 dose-escalation trial. Leukemia & Lymphoma 60:9, pages 2291-2294.
Read now
Georg Hopfinger, Robert Griessl, Eveline Sifft, Ninon Taylor, Lukas Kenner, Richard Greil & Olaf Merkel. (2012) Novel treatment avenues for peripheral T-cell lymphomas. Expert Opinion on Drug Discovery 7:12, pages 1149-1163.
Read now
Pier Luigi Zinzani, Paolo Corradini, Andrea Gallamini, Alberto Grossi, Mario Lazzarino, Monia Marchetti, Maurizio Martelli, Giuseppe Rossi & Umberto Vitolo. (2012) Overview of alemtuzumab therapy for the treatment of T-cell lymphomas. Leukemia & Lymphoma 53:5, pages 789-795.
Read now
Fernando Roncolato, Anna Gazzola, Pier Luigi Zinzani, Stefano A Pileri & Pier Paolo Piccaluga. (2011) Targeted molecular therapy in peripheral T-cell lymphomas. Expert Review of Hematology 4:5, pages 551-562.
Read now
Rebecca A Howman & H Miles Prince. (2011) New drug therapies in peripheral T-cell lymphoma. Expert Review of Anticancer Therapy 11:3, pages 457-472.
Read now

Articles from other publishers (16)

Milos D. Miljkovic, Sigrid P. Dubois, Jürgen R. Müller, Bonita Bryant, Elaine Ma, Kevin C. Conlon & Thomas A. Waldmann. (2023) Interleukin-15 augments NK cell–mediated ADCC of alemtuzumab in patients with CD52+ T-cell malignancies. Blood Advances 7:3, pages 384-394.
Crossref
Daniel Ren Yi Yap, Jing Quan Lim, Dachuan Huang, Choon Kiat Ong & Jason Yongsheng Chan. (2023) Emerging predictive biomarkers for novel therapeutics in peripheral T-cell and natural killer/T-cell lymphoma. Frontiers in Immunology 14.
Crossref
Claudio Ortolani. 2021. Flow Cytometry of Hematological Malignancies. Flow Cytometry of Hematological Malignancies 301 427 .
Erin Mulvey & Jia Ruan. (2020) Biomarker-driven management strategies for peripheral T cell lymphoma. Journal of Hematology & Oncology 13:1.
Crossref
Adetokunbo Oluwasanjo, Saritha Kartan, William Johnson, Onder Alpdogan, Alejandro Gru, Anjali Mishra, Bradley M. Haverkos, Jerald Gong & Pierluigi Porcu. 2019. T-Cell and NK-Cell Lymphomas. T-Cell and NK-Cell Lymphomas 83 98 .
Thomas A. Rasmussen, James McMahon, J. Judy Chang, Jori Symons, Michael Roche, Ashanti Dantanarayana, Afam Okoye, Bonnie Hiener, Sarah Palmer, Wen Shi Lee, Stephen J. Kent, Carrie Van Der Weyden, H. Miles Prince, Paul U. Cameron & Sharon R. Lewin. (2017) Impact of alemtuzumab on HIV persistence in an HIV-infected individual on antiretroviral therapy with Sezary syndrome. AIDS 31:13, pages 1839-1845.
Crossref
Davis Seelig, Anne Avery, E. Ehrhart & Michael Linden. (2016) The Comparative Diagnostic Features of Canine and Human Lymphoma. Veterinary Sciences 3:2, pages 11.
Crossref
P Corradini, U Vitolo, A Rambaldi, R Miceli, F Patriarca, A Gallamini, A Olivieri, F Benedetti, G Todeschini, G Rossi, F Salvi, B Bruno, L Baldini, A Ferreri, C Patti, C Tarella, S Pileri & A Dodero. (2014) Intensified chemo-immunotherapy with or without stem cell transplantation in newly diagnosed patients with peripheral T-cell lymphoma. Leukemia 28:9, pages 1885-1891.
Crossref
Koppany Visnyei, Michael L. Grossbard & Ilan Shapira. (2013) Hepatosplenic γδ T-cell Lymphoma: An Overview. Clinical Lymphoma Myeloma and Leukemia 13:4, pages 360-369.
Crossref
Stefano A. Pileri & Pier Paolo Piccaluga. (2012) New molecular insights into peripheral T cell lymphomas. Journal of Clinical Investigation 122:10, pages 3448-3455.
Crossref
Bettina Bisig, Philippe Gaulard & Laurence de Leval. (2012) New biomarkers in T-cell lymphomas. Best Practice & Research Clinical Haematology 25:1, pages 13-28.
Crossref
Kerry J. Savage, Andrés J.M. Ferreri, Pier Luigi Zinzani & Stefano A. Pileri. (2011) Peripheral T-cell lymphoma – Not otherwise specified. Critical Reviews in Oncology/Hematology 79:3, pages 321-329.
Crossref
Claudio Ortolani. 2011. Flow Cytometry of Hematological Malignancies. Flow Cytometry of Hematological Malignancies 160 300 .
H.C. Kluin-Nelemans, M. van Marwijk Kooy, P.J. Lugtenburg, W.L.J. van Putten, M. Luten, J. Oudejans & G.W. van Imhoff. (2011) Intensified alemtuzumab–CHOP therapy for peripheral T-cell lymphoma. Annals of Oncology 22:7, pages 1595-1600.
Crossref
Y Saito, S Nakahata, N Yamakawa, K Kaneda, E Ichihara, A Suekane & K Morishita. (2011) CD52 as a molecular target for immunotherapy to treat acute myeloid leukemia with high EVI1 expression. Leukemia 25:6, pages 921-931.
Crossref
Francine M. Foss. (2011) Molecular Predictors of Response in Aggressive T-cell Lymphomas. The Cancer Journal 17:2, pages 142-148.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.